Shares of Landauer, Inc. (NYSE:LDR) have been given a consensus broker rating score of 4.00 (Sell) from the two brokers that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a strong sell recommendation and one has given a hold recommendation to the company. Landauer’s rating score has declined by 9% from three months ago as a result of a number of analysts’ upgrades and downgrades.

Brokerages have set a 1-year consensus target price of $44.50 for the company, according to Zacks. Zacks has also assigned Landauer an industry rank of 218 out of 265 based on the ratings given to related companies.

Separately, Zacks Investment Research cut Landauer from a “hold” rating to a “sell” rating in a report on Thursday, June 29th.

COPYRIGHT VIOLATION WARNING: This news story was first reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/07/04/analysts-set-44-50-target-price-for-landauer-inc-nyseldr.html.

Landauer (LDR) traded up 2.96% during mid-day trading on Tuesday, reaching $53.85. The company’s stock had a trading volume of 14,263 shares. The stock’s 50-day moving average is $52.27 and its 200-day moving average is $50.87. Landauer has a 12 month low of $37.89 and a 12 month high of $55.80. The firm has a market capitalization of $519.06 million, a PE ratio of 26.80 and a beta of 1.29.

Landauer (NYSE:LDR) last issued its earnings results on Tuesday, May 9th. The scientific and technical instruments company reported $0.54 EPS for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.04. Landauer had a return on equity of 79.41% and a net margin of 12.82%. The company had revenue of $39.12 million during the quarter. On average, equities analysts anticipate that Landauer will post $1.79 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 6th. Investors of record on Friday, June 16th will be issued a $0.275 dividend. This represents a $1.10 dividend on an annualized basis and a yield of 2.04%. The ex-dividend date is Wednesday, June 14th. Landauer’s dividend payout ratio is presently 54.46%.

A number of large investors have recently modified their holdings of the company. Mason Street Advisors LLC raised its position in shares of Landauer by 7.2% in the first quarter. Mason Street Advisors LLC now owns 2,250 shares of the scientific and technical instruments company’s stock worth $110,000 after buying an additional 151 shares in the last quarter. Contravisory Investment Management Inc. acquired a new stake in Landauer during the first quarter worth $179,000. Tower Research Capital LLC TRC boosted its stake in Landauer by 8,839.3% in the first quarter. Tower Research Capital LLC TRC now owns 5,006 shares of the scientific and technical instruments company’s stock worth $244,000 after buying an additional 4,950 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in Landauer by 5.6% in the fourth quarter. Thrivent Financial for Lutherans now owns 5,130 shares of the scientific and technical instruments company’s stock worth $247,000 after buying an additional 270 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in Landauer by 2.0% in the first quarter. Arizona State Retirement System now owns 5,061 shares of the scientific and technical instruments company’s stock worth $247,000 after buying an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 82.91% of the company’s stock.

Landauer Company Profile

Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.

Get a free copy of the Zacks research report on Landauer (LDR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.